People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Pharma, Software / Tech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RadImmune Therapeutics, Inc. | — | Pharma | Series A | $13.6M | $420.0M | 2019 |
| SB Technology, Inc. | — | Software / Tech | Series A | $6.3M | $20.7M | 2022 |
| Primary Insight, LLC | — | Other | Seed | $2.0M | $38.1M | 2010 |
Jack Hidary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack Hidary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Silverman | 1 | 15 |
| Eric Schmidt | 1 | 6 |
| Thomas Wheeler | 1 | 4 |
| Josh Becker | 1 | 2 |
| Fany Fang | 1 | 1 |
| Leighton Thomas | 1 | 1 |
| David DeRose | 1 | 1 |
| Michael Hidary | 1 | 1 |
| Robert Mitgang | 1 | 1 |
| Ron Lennox | 1 | 1 |
| Murray Hidary | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.